The database of 200 million protein-structure predictions now includes homodimers, adding new biological relevance.

Nvidia has a structured data enablement strategy. Nvidia provides libaries, software and hardware to index and search data ...

Structure Therapeutics (GPCR) stock jumped 10% after its GLP-1 pill aleniglipron posted 16.3% weight loss, outperforming Lilly and Novo's oral candidates.

Modern software increasingly depends on data structures that go far beyond basic arrays and trees. Some of the most powerful systems rely on designs that rarely appear in traditional programming ...

Structure Therapeutics’ aleniglipron Phase 2 shows ~16% placebo-adjusted weight loss; a best-in-class oral GLP-1 with strong cash runway.

Nvidia will structure hundreds of zettabytes per year of unstructured data to make it the ground truth for AI. AI will ...

A new collaboration between EMBL's European Bioinformatics Institute (EMBL-EBI), Google DeepMind, NVIDIA, and Seoul National University has made millions of AI-predicted protein complex structures ...

Researchers from the Johns Hopkins Kimmel Cancer Center and The Johns Hopkins University have created a novel database structure that allows investigators anywhere to more easily study multiple types ...

Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an oral GLP-1 drug, as the obesity biotech readies the candidate for phase 3. The ...

Structure Therapeutics stock jumped 5.4%, closing at $56.65 on Monday, when it touted 16% weight loss - about 39 pounds – demonstrated by aleniglipron as the best results yet for an oral GLP-1 drug.

Structure Therapeutics’ oral obesity drug elicited a placebo-adjusted weight loss of 16.3% at 44 weeks in a Phase 2 trial.

Newhedge.io, a Bitcoin analytics platform focused on on-chain market intelligence, today announced the launch of the Newhedge API, providing developers, institutions, and analysts with direct ...